Journal article
Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation
Bioorganic & medicinal chemistry letters, v 19(10), pp 2661-2663
15 May 2009
PMID: 19375913
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
A series of guanidine triazinediones were identified as potent PK1 receptor antagonists. A compound in this series inhibited the PK1 invoked prosecretory response in rat ileum tissue. (C) 2009 Elsevier Ltd. All rights reserved.
Metrics
Details
- Title
- Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation
- Creators
- Janet L. Ralbovsky - Johnson & Johnson (United States)Joseph G. Lisko - Johnson & Johnson (United States)Jeffrey M. Palmer - Johnson & Johnson (United States)John Mabus - Johnson & Johnson (United States)Kristen M. Chevalier - Johnson & Johnson (United States)Mark J. Schulz - Johnson & Johnson (United States)Alexey B. Dyatkin - Johnson & Johnson (United States)Tamara A. Miskowski - Johnson & Johnson (United States)Steven J. Coats - Johnson & Johnson (United States)Pamela Hornby - Johnson & Johnson (United States)Wei He - Johnson & Johnson (United States)
- Publication Details
- Bioorganic & medicinal chemistry letters, v 19(10), pp 2661-2663
- Publisher
- Elsevier
- Number of pages
- 3
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pharmacology and Physiology
- Web of Science ID
- WOS:000265627800010
- Scopus ID
- 2-s2.0-65349195100
- Other Identifier
- 991021931777204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Chemistry, Medicinal
- Chemistry, Organic